Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rozerem for Sleep Disturbance After Traumatic Brain Injury
NCT01207050Phase 4Unknown
- Sponsor
- Kessler Foundation
- Start
- Sep 2010
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Insomnia comparing Rozerem (Ramelteon) with Placebo (2 arms). Primary endpoint: Sleep Quality at 3 weeks. Status: unknown.
02
Drugs
ramelteon
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT01207050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01207050.